Activation and induction of cytosolic phospholipase A2 by IL-1β in human tracheal smooth muscle cells: Role of MAPKs/p300 and NF-κB

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 1045-1056

  Lee, Chiang Wen ^a   Lee, I Ta ^b   Lin, Chih Chung ^b   Lee, Hui Chun ^b   Lin, Wei Ning ^b   Yang, Chuen Mao ^b  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cytosolic phospholipase A2; IL 1 ; NF B; p300; PGE2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; HELENALIN; HISTONE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PROTEIN P300; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1;

ACETYLATION; ARTICLE; CYTOSOL; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; TRACHEA;

DINOPROSTONE; E1A-ASSOCIATED P300 PROTEIN; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; TRACHEA; TRANSCRIPTION, GENETIC;

EID: 77950377041     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22488     Document Type: Article

References (44)

1. 2. Annu Rev Pharmacol Toxicol 39:175-189.
2. Barnes PJ. 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 83:1013-1026.
3. Barnes PJ, Karin M. 1997. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
4. Bian ZM, Elner SG, Yoshida A, Kunkel SL, Su J, Elner VM. 2001. Activation of p38, ERK1/2 and NIK pathways is required for IL-1β and TNF-α-induced chemokine expression in human retinal pigment epithelial cells. Exp Eye Res 73:111-121.
5. 2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J Biol Chem 276:42737-42743.
6. 2) function: Insights from the knockout mouse. Adv Exp Med Biol 507: 25-31.
7. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. 1992. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 89:958-967.
8. Cao D, Bromberg PA, Samet JM. 2007. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. Am J Respir Cell Mol Biol 37:232-239.
9. Chan HM, La Thangue NB. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114:2363-2373.
10. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 22:1-2.
11. DeWitt DL. 1999. Cox-2-selective inhibitors: The new super aspirins. Mol Pharmacol 55:625-631.
12. 2. Cell Signal 14:199-204.
13. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
14. 2 production by lung fibroblasts. Am J Respir Cell Mol Biol 30:91-100.
15. Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev 14:1553-1577.
16. 2 activity. Biochim Biophys Acta 1127:163-167.
17. Henderson WR, Jr., Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY. 2002. A role for cysteinyl leukotrienes in airway remodeling in amouse asthma model. Am J Respir Crit Care Med 165:108-116.
18. 2. Biol Pharm Bull 27:1168-1173.
19. 2 expression via sequential PKC-δ, p42/p44 MAPK, and NF-κB activation in rat brain astrocytes. J Cell Physiol 206:246-254.
20. 2. Arthritis Rheum 37:653-661.
21. Hung JJ, Wang YT, Chang WC. 2006. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol 26:1770-1785.
22. Khanapure SP, Garvey DS, Janero DR, Letts LG. 2007. Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem 7:311-340.
23. Lee CW, Chien CS, Yang CM. 2004. Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 286:L921-L930.
24. Lee CW, Lin CC, Lin WN, Liang KC, Luo SF, Wu CB, Wang SW, Yang CM. 2007. TNF-α induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-κB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292:L799-L812.
25. Lee IT, Wang SW, Lee CW, Chang CC, Lin CC, Luo SF, Yang CM. 2008. Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. J Immunol 181:5098-5110.
26. 2. J Biol Chem 272:16709-16712.
27. Lin CC, Sun CC, Luo SF, Tsai AC, Chien CS, Hsiao LD, Lee CW, Hsieh JT, Yang CM. 2004. Induction of cyclooxygenase-2 expression in human tracheal smooth muscle cells by interleukin-1β: Involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kB. J Biomed Sci 11: 377-390.
28. 2 by lipopolysaccharide in canine tracheal smooth muscle cells: Involvement of MAPKs and NF-κB pathways. Cell Signal 18:1201-1211.
29. 2 expression in canine tracheal smooth muscle cells. Toxicol Appl Pharmacol 232:396-407.
30. Marshall CJ. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4:82-89.
31. 2. Nat Immunol 1:42-46.
32. Nie M, Pang L, Inoue H, Knox AJ. 2003. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1β in human airway smooth muscle cells: Involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol Cell Biol 23:9233-9244.
33. Poizat C, Puri PL, Bai Y, Kedes L. 2005. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 25:2673-2687.
34. Roth SY, Denu JM, Allis CD. 2001. Histone acetyltransferases. Annu Rev Biochem 70:81-120.
35. 2 in rat mesangial cells. Biochem Biophys Res Commun 174:268-275.
36. 2 enzymes: Classification and characterization. Biochim Biophys Acta 1488:1-19.
37. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. 2000. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol Chem 275:14838-14845.
38. 2 in allergic response and parturition. Nature 390:618-622.
39. 2 expression and inflammation: The relationship with associated disease states. J Lipid Mediat 8:1-30.
40. 2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem 276:1226-1232.
41. Wang CC, Lin WN, Lee CW, Lin CC, Luo SF, Wang JS, Yang CM. 2005. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-κB in IL-1β-induced VCAM-1 expression in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288:L227-L237.
42. Wang YN, Chen YJ, Chang WC. 2006. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol Pharmacol 69:85-98.
43. Yang CM, Chien CS, Hsiao LD, Luo SF, Wang CC. 2002. Interleukin-1β- induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-κB pathways in canine tracheal smooth muscle cells. Cell Signal 14:899-911.
44. Yang CM, Hsieh HL, Lee CW. 2005. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med J 28:813-823.